GLP Watchdog

Gala vs Wisp

Neither Gala nor Wisp has an FDA warning letter on record. No price lines up like for like: Gala and Wisp publish prices for different products.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Gala / Wisp

Featured pick (affiliate partner)

Gala logo

Gala

8.5/10

Wisp logo

Wisp

7.1/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$179/moCompounded semaglutide injection
$225/moCompounded oral semaglutide
States
All 50 states
39 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit Gala
Visit Wisp

Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Wisp pays us nothing. The scores are computed the same way for both and are shown as computed (Gala 8.5, Wisp 7.1). How we are paid

What the record shows

  1. 01

    Neither Gala nor Wisp has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    No price lines up like for like: Gala and Wisp publish prices for different products.

  4. 04

    Only Gala lists a price for compounded semaglutide injection, compounded tirzepatide injection and brand-name semaglutide pen. Only Wisp lists a price for compounded oral semaglutide.

  5. 05

    Gala covers 11 states Wisp does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Gala

Wisp

Compounded semaglutide injection

$179/mo

$2,148 a year

Not sold or not priced
Compounded tirzepatide injection

$179/mo

$2,148 a year

Not sold or not priced
Brand-name semaglutide pen

$1,299/mo

$15,588 a year

Not sold or not priced
Compounded oral semaglutide
Not sold or not priced

$225/mo

$2,700 a year

Price includes
Medication, clinician visits, shipping
Medication, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
Yearly plan for the $179 rate; 72 hours' notice before the billing date to cancel
Not stated
Refunds
No refund on cancellation; full refund only if the medical provider disqualifies you
All sales are final

Read off each seller’s own pages. Gala: October 17, 2026. Wisp: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Gala

8.5/10
Featured pick (affiliate partner)
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Wisp does not price
  • Lists 50 states against 39
  • Names no compounding pharmacy
Visit Gala

The case for Wisp

7.1/10
  • Sells compounded oral semaglutide, which Gala does not price
  • Names no compounding pharmacy
Visit Wisp

Scores

Gala 8.5 · Wisp 7.1 out of 10. Six weighted parts.

Value25%

7.9A
vs
B
4.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
7.5

Accessibility10%

10.0A
vs
B
8.2

Support10%

7.0A
vs
B
4.5

The score is the same formula for every seller. Payment does not enter it. Method

Gala vs Wisp: questions

Neither Gala nor Wisp has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
No price lines up like for like: Gala and Wisp publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Gala states you can cancel at any time; refunds: no refund on cancellation; full refund only if the medical provider disqualifies you. Wisp states you can cancel at any time; refunds: all sales are final.
Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Wisp pays us nothing. The scores are computed the same way for both and are shown as computed (Gala 8.5, Wisp 7.1).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks